Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Betsy Barnes(Feinstein Institute for Medical Research), José M. Adrover(Cold Spring Harbor Laboratory), Amelia Baxter-Stoltzfus(Cornell University), Alain Borczuk(Cornell University), Jonathan Cools‐Lartigue, James M. Crawford(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Juliane Daßler‐Plenker(Cold Spring Harbor Laboratory), Philippe Guerci(Centre Hospitalier Régional et Universitaire de Nancy), Caroline Huynh(McGill University Health Centre), Jason S. Knight(University of Michigan), Massimo Loda(Cornell University), Mark R. Looney(University of California, San Francisco), Florencia McAllister(The University of Texas MD Anderson Cancer Center), Roni Rayes(McGill University Health Centre), Stéphane Renaud(Centre Hospitalier Régional et Universitaire de Nancy), Simon Rousseau(McGill University Health Centre), Steven Salvatore(Cornell University), Robert E. Schwartz(Cornell University), Jonathan Spicer(McGill University Health Centre), Christian C. Yost(University of Utah), Andrew Weber(Northwell Health), Yu Zuo(University of Michigan), Mikala Egeblad(Cold Spring Harbor Laboratory)
The Journal of Experimental Medicine
April 16, 2020
Cited by 1,577Open Access
Full Text

Abstract

Coronavirus disease 2019 (COVID-19) is a novel, viral-induced respiratory disease that in ∼10-15% of patients progresses to acute respiratory distress syndrome (ARDS) triggered by a cytokine storm. In this Perspective, autopsy results and literature are presented supporting the hypothesis that a little known yet powerful function of neutrophils-the ability to form neutrophil extracellular traps (NETs)-may contribute to organ damage and mortality in COVID-19. We show lung infiltration of neutrophils in an autopsy specimen from a patient who succumbed to COVID-19. We discuss prior reports linking aberrant NET formation to pulmonary diseases, thrombosis, mucous secretions in the airways, and cytokine production. If our hypothesis is correct, targeting NETs directly and/or indirectly with existing drugs may reduce the clinical severity of COVID-19.


Related Papers

No related papers found

Powered by citation graph analysis